Environmental lead exposure and the kidney

Clinical Toxicology

Volumn 26, Issue 1-2, 1988, Pages 1-34

  Bernard, Bruce P ^a   Becker, Charles E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEAD;

ENVIRONMENTAL EXPOSURE; HUMAN; KIDNEY FUNCTION; NEPHROTOXICITY; REVIEW;

ANIMAL; ENVIRONMENTAL EXPOSURE; HUMAN; KIDNEY; LEAD; SUPPORT, NON-U.S. GOV'T;

EID: 0023927411     PISSN: 15563650     EISSN: None     Source Type: Journal    
DOI: 10.3109/15563658808995395     Document Type: Article

References (119)

1. Review of toxicology of inorganic lead
2. Does lead contribute to deterioration of renal function in patients with renal disease?
3. EDTA lead-mobilization and bone lead concentration in occult lead intoxication
4. Occupational exposure to lead: effects on renal function
5. Lead Intoxication
6. The effects of lead on the kidney
7. Saturnine gout among Roman Aristocracts
8. Nephrite et arthrite saturnines: coincidence de ces affections: parallele avec la nephrite et l'arthrite gouteusses
9. De albuminurie saturnine
10. Some Aspects of lead absorption
11. Mortality of lead workers
12. Mortality of battery pasters and lead workers
13. The pathology and pathogenesis of chronic lead nephropathy occurring in Queensland
14. An investigation of the extraordinary incidence of chronic nephritis in young people in Queensland
15. Chronic nephritis in Queensland
16. The lead content of bone in chronic Bright's disease
17. Lead Nephropathy
18. The nature of the primary renal lesion produced by lead
19. Renal lesions in experimental plumbism and their clinical implications
20. Lead intoxication during development: its late effects on kidney function and blood pressure
21. Lead and protein content of isolated intranuclear inclusion bodies from kidneys of lead-poisoned rats
22. Resistance of the rat to development of lead-induced renal functional deficits
23. An ultrastructural reevaluation of lead-induced pathology in the kidney
24. A study of the relative toxicity of the molecular compounds of lead arsenate
25. Intranuclear inclusions and renal tumors in rats fed lead subacetate
26. Intranuclear inclusion bodies in the kidney and liver caused by lead poisoning
27. Ultrastructural and ultrahistochemical investigations of lead-induced intranuclear inclusion bodies in rat kidney
28. The induction of renal tumours by feeding basic lead acetate to mice and hamsters
29. Experimental oral lead toxicity in young dogs: Clinical and morphologic effects
30. Relations between lead poisoning in rabbit and man
31. Biogenesis of intranuclear lead-protein inclusions in mouse kidney
32. Chronic low level toxicity in the rat, III: An integrated toxicological assessment with special reference to the kidney
33. Lead and the kidney
34. Pathobiological and behavioral effects of intoxication in the infant rhesus monkey
35. Early appearance and localization of intranuclear inclusions in the segments of renal proximal tubules of rats following ingestion of lead
36. Effects of lead inclusion bodies on subcellular distribution of lead in rat kidney: the relationship to mitochondrial function
37. Cell proliferation in mouse kidney induced by lead: I. Synthesis of DNA
38. The effect of chronic lead poisoning on arterial blood pressure in rats
39. Postmortem studies on hypertensive rats chronically intoxicated with lead acetate
40. Chronic low-level lead exposure: its role in the pathogenesis of hypertension
41. Kinetics of lead retention and distribution in suckling and adult rats
42. Neonatal lead exposure in the rat
43. Effect of chronic lead treatment on renal function
44. The mongolian Gerbil as a model for chronic lead toxicity
45. A comparison of concentration of lead in human tissues
46. Temporal stability of blood lead concentrations in adults exposed only to environmental lead
47. Effects of Lead on the Kidney
48. Trends in the blood lead levels of the U.S. population: The second national health and nutrition examination survey (NHANES II) 1976–1980
49. House and hand dust as a potential source of childhood lead exposure
50. Increased lead absorption in inner city children: where does the lead come from?
51. Lead poisoning in children of lead workers: home contamination with industrial dust
52. Chronic nephritis due to ingestion of lead contaminated flour
53. Kinetic analysis of lead metabolism in healthy humans
54. Elimination kinetics of blood lead in workers with chronic lead intoxication
55. Lead exposure and renal failure: does renal insufficiency influence lead kinetics?
56. Occupational lead nephropathy
57. The safety of the EDTA mobilization test
58. Assessment of the body burden of chelatable lead: A model and its application to lead workers
59. The effects of chelating agents on the tissue distribution and excretion of lead
60. Recognition and management of children with increased lead absorption
61. Blood lead - An inadequate measure of occupational exposure
62. The role of lead in renal failure
63. DMSA, DMPS, and DMPA - as arsenic antidotes
64. DMSA and DMPS - Water soluble antidotes for heavy metal poisoning
65. Early detection of the nephrotoxic effects of industrial chemicals: State of the art and future prospects
66. Renal function impairment in lead exposed workers: correlations with zinc protoporphyrin and blood lead levels
67. Increased urinary enzyme excretion in workers exposed to nephrotoxic chemicals
68. Spectrum of tests available to evaluate occupationally induced renal disease
69. Renal function 9–17 years after childhood lead poisoning
70. Lead dosage and the role of the intranuclear inclusion body
71. Renal ultrastructure, renal function, and parameter of lead toxicity in workers with different periods of lead exposure
72. Nephropathy in chronic lead poisoning
73. A follow-up of cases of plumbism in children
74. Renal function subsequent to childhood plumbism
75. Chronic lead nephropathy in Queensland: alternative methods of diagnosis
76. Renal insufficiency associated with excessive lead exposure
77. Blood lead concentration, blood pressure and renal function
78. Lead poisoning from drinking “moonshine” whiskey
79. Nephropathy in chronic lead poisoning
80. Chronic renal failure with gout: a marker for chronic lead poisoning
81. Chronic lead ingestion and gout
82. Subclinical lead exposure: a possible cause of gout
83. Second communication on the blood and effused fluids in gout, rheumatism and Bright's disease
84. Saturnine gout, and its distinguishing marks
85. Calcium versenate in the diagnosis of chronic lead nephropathy
86. Chronic lead nephropathy: the diagnostic use of calcium-EDTA and the association with gout
87. The clinical differentiation of lead gout from primary gout
88. Chronic lead nephropathy
89. The lead content of bone in subjects without recognized past lead exposure and in patients with renal disease
90. The clinical differentiation of primary gout from primary renal disease in patients with both gout and renal diseases
91. Pathogenesis of hyperuricemia in saturnine gout
92. Gout and saturnism
93. The role of lead in gout nephropathy
94. Patterns of lead excretion in patients with gout and chronic renal failure - a combined German and Australian study
95. Occult lead intoxication in patients with gout and kidney disease
96. Moonshine and lead
97. Chronic lead accumulation as a possible cause of renal failure in patients with gout
98. Urinary lead excretion in uremic patients
99. Relationship of blood lead and blood pressure in the adolescent and adult U.S. population
100. The relationship between blood lead levels and blood pressure and its cardiovascular risk implications
101. The relationship of blood lead to blood pressure in a longitudinal study of working men
102. Clinical studies on lead absorption in the human
103. Health of lead exposed storage battery workers
104. A follow-up study of lead workers
105. Mortality among employees of lead battery plants and lead-producing plants, 1947 – 1980
106. Long-term mortality profile of heavily-exposed lead smelter workers
107. Contribution of lead to hypertension with renal impairment
108. Occupational exposure to lead and blood pressure: A study in 105 workers
109. Prevalence of lead disease answering secondary lead smelters and biological indicators of exposure